Gain Therapeutics (GANX) Short term Debt (2020 - 2026)
Gain Therapeutics' Short term Debt came in at $123,628 for Q2 2026, down 2.0% from $126,108 a year earlier but up 23.3% from the prior quarter.
Powered by 
Analysis
Gain Therapeutics (GANX) Short term Debt (2020 - 2026) Analysis & Trends
At the end of FY2025, Gain Therapeutics' Short term Debt was $100,869, down 8.4% from FY2024.
- Short term Debt carries a five-year compound annual growth rate of 34.8% (FY2020 to FY2025).
- Going back by year, Short term Debt was $110,177 in FY2024 (-7.3%), $118,797 in FY2023 (+9.9%), $108,135 in FY2022 (+4.2%) and $103,826 in FY2021 (+358.9%).
- The five-year range for quarterly Short term Debt is $83,747 (Q2 2022) to $126,108 (Q2 2025).
- Year-over-year, Short term Debt has declined for three consecutive quarters, with growth averaging 0.1% over the last eight quarters.
- The fastest year-over-year change in Short term Debt over five years came in Q4 2021 (growth of 358.9%), and the weakest in Q1 2026 (a decline of 11.4%).
- Business Quant data shows GANX's Short term Debt at $100,281 (Q1 2026), $100,869 (Q4 2025) and $125,545 (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.22 Bn | 1,133.81 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 646.28 Bn | 566.14 Bn | 17.30 Bn |
| 3 | AbbVie | 503.17 Bn | 476.28 Bn | 12.70 Bn |
| 4 | Merck | 365.23 Bn | 319.60 Bn | 12.21 Bn |
| 5 | Novartis Ag | 302.66 Bn | 266.65 Bn | 11.24 Bn |
| 6 | Astrazeneca | 267.39 Bn | 241.08 Bn | 12.86 Bn |
| 7 | Amgen | 241.61 Bn | 197.01 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn |
| 9 | Pfizer | 172.91 Bn | 119.55 Bn | 10.94 Bn |
| 10 | Gain Therapeutics | 54.89 Mn | -4.40 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 123,628.00 |
| Mar 31, 2026 | 100,281.00 |
| Dec 31, 2025 | 100,869.00 |
| Sep 30, 2025 | 125,545.00 |
| Jun 30, 2025 | 126,108.00 |
| Mar 31, 2025 | 113,121.00 |
| Dec 31, 2024 | 110,177.00 |
| Sep 30, 2024 | 118,280.00 |
| Jun 30, 2024 | 111,051.00 |
| Mar 31, 2024 | 110,848.00 |
| Dec 31, 2023 | 118,797.00 |
| Sep 30, 2023 | 109,281.00 |
| Jun 30, 2023 | 111,636.00 |
| Mar 31, 2023 | 109,200.00 |
| Dec 31, 2022 | 108,135.00 |
| Sep 30, 2022 | 101,260.00 |
| Jun 30, 2022 | 83,747.00 |
| Mar 31, 2022 | 86,624.00 |
| Dec 31, 2021 | 103,826.00 |
| Sep 30, 2021 | 86,645.00 |
API Access
Gain Therapeutics Short term Debt API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=short-term-debt&ticker=GANX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "short-term-debt", "ticker": "GANX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=short-term-debt&ticker=GANX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();